← All companies
ALNY annual revenue
ALNYLAM PHARMACEUTICALS, INC.
ALNY - CIK 0001178670
Market cap$37.51 B
Rank#405
SEC filings1,651
ALNYLAM PHARMACEUTICALS, INC. revenue by year
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported revenue of $3.71B for fiscal year 2025, as filed in its audited annual report with the SEC.
ALNY revenue 2008-2025
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $3.71B | +65.2% |
| FY 2024 | $2.25B | +23.0% |
| FY 2023 | $1.83B | +76.2% |
| FY 2022 | $1.04B | +22.9% |
| FY 2021 | $844.29M | +71.3% |
| FY 2020 | $492.85M | +124.3% |
| FY 2019 | $219.75M | +193.4% |
| FY 2018 | $74.91M | -16.7% |
| FY 2017 |
Revenue of similar companies
Frequently asked questions
How much revenue does ALNYLAM PHARMACEUTICALS, INC. make?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported revenue of $3.71B for fiscal year 2025, as filed in its audited annual report with the SEC.
How has ALNYLAM PHARMACEUTICALS, INC.'s revenue changed over time?
Between fiscal 2008 and fiscal 2025, ALNYLAM PHARMACEUTICALS, INC.'s revenue grew from $96.16M to $3.71B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.